慢性肾脏病血脂异常的干预处理分析

目的探讨更有效治疗慢性肾脏病血脂异常的方法。方法随机将58例肾病综合征且合并高血脂患者分为观察组、对照组各29例。观察组给予血脂康调脂治疗,对照组给予辛伐他汀治疗。结果两组治疗前后TG、TC、LDL-C及HDL-C水平均有显著性差异(P<0.05)。治疗后两组各血脂指标比较无统计学差异(P>0.05)。两组TG、TC及HDL-C总有效率比较均无显著性差异(P>0.05)。结论血脂康调脂疗效与辛伐他汀疗效相当,两组均具有显著调脂疗效。

Objective To explore more effective treatment of chronic renal diseases with hyperlipidemia. Methods 58 patients of nephrotic syndrome with hyperlipidemia were divided into the observation group（n=29） and the control group（n=29）. The observation group were given by Xuezhikang,and the control group were given by Simvastatin. Results The differences in TG,TC,LDL-C and HDL-C were significant in both groups before and after therapy（P0.05）.There is no differences in two groups after therapy（P0.05）.The total effective rates of TG,TC and HDL-C between two groups are no difference（P0.05）. Conclusion Both Xuezhikang and Hyperlipidemia are effective to treatment to nephrotic syndrome with hyperlipidemia.